REVB Revelation Biosciences Inc
3,702
$1.83
$0.08
(4.19%)
| Watchers | 3,702 |
| 52-Wk Low | $1.78 |
| 52-Wk High | $35.40 |
| Market Cap | $2.99M |
| Volume | 35,473.00 |
| 52-Wk High | $35.40 |
| 52-Wk Low | $1.78 |
Revelation Biosciences, Inc. Announces Financial Results for the Three Months Ended March 31, 2024Business Wire • 15 days ago
Revelation Biosciences, Inc. (NASDAQ: REVB) (the Company or Revelation), a clinical-stage life sciences company that is focused on harnessing the power of trained immunity for the prevention and...
Share to Feed
Revelation Biosciences, Inc. (NASDAQ:REVB Free Report) Stock analysts at Zacks Small Cap dropped their Q1 2024 earnings per share estimates for shares of Revelation Biosciences in a...
Revelation Biosciences (NASDAQ:REVB Get Free Report) announced its quarterly earnings results on Friday. The company reported ($8.33) earnings per share (EPS) for the quarter, beating the...
Revelation Biosciences Inc. (REVB) has disclosed a new risk, in the Regulation category. Revelation Biosciences Inc. faces significant risk due to...
Revelation Biosciences, Inc. (NASDAQ: REVB) (the Company or Revelation), a clinical-stage life sciences company that is focused on harnessing the power of trained immunity for the prevention and...
Revelation Biosciences Inc. (NASDAQ: REVB) (the Company or Revelation) a clinical-stage life sciences company that is focused on harnessing the power of trained immunity for the prevention and...
Revelation Biosciences Inc. (NASDAQ: REVB) (the Company or Revelation) a clinical-stage life sciences company that is focused on harnessing the power of trained immunity for the prevention and...
Revelation Biosciences Inc. (NASDAQ: REVB) (the Company or Revelation) a clinical-stage life sciences company that is focused on harnessing the power of trained immunity for the prevention and...
Revelation Biosciences Inc. (NASDAQ: REVB) (the Company or Revelation), announced today that, as part of a limited number of accepted abstract authors, the company was invited to give an oral...
Revelation Biosciences Inc. (NASDAQ: REVB) (the Company or Revelation), a life sciences company that is focused on harnessing the power of trained immunity for the prevention and treatment of...